Cargando…

A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice

Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Yasuo, Tachikawa, Masanori, Obuchi, Wataru, Hoshi, Yutaro, Tomioka, Yusuke, Ohtsuki, Sumio, Terasaki, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691662/
https://www.ncbi.nlm.nih.gov/pubmed/23758935
http://dx.doi.org/10.1186/2045-8118-10-21
_version_ 1782274508556599296
author Uchida, Yasuo
Tachikawa, Masanori
Obuchi, Wataru
Hoshi, Yutaro
Tomioka, Yusuke
Ohtsuki, Sumio
Terasaki, Tetsuya
author_facet Uchida, Yasuo
Tachikawa, Masanori
Obuchi, Wataru
Hoshi, Yutaro
Tomioka, Yusuke
Ohtsuki, Sumio
Terasaki, Tetsuya
author_sort Uchida, Yasuo
collection PubMed
description Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the identified proteins must also be elucidated, but this is complicated by the inability of conventional proteomic methods to yield quantitative information for protein expression. Thus, a variety of biological systems remain “black boxes”. Quantitative targeted absolute proteomics (QTAP) enables the determination of absolute expression levels (mol) of any target protein, including low-abundance functional proteins, such as transporters and receptors. Therefore, QTAP will be useful for understanding the activities and roles of individual proteins and their differences, including normal/disease, human/animal, or in vitro/in vivo. Here, we describe the study protocols and precautions for QTAP experiments including in silico target peptide selection, determination of peptide concentration by amino acid analysis, setup of selected/multiple reaction monitoring (SRM/MRM) analysis in liquid chromatography–tandem mass spectrometry, preparation of protein samples (brain capillaries and plasma membrane fractions) followed by the preparation of peptide samples, simultaneous absolute quantification of target proteins by SRM/MRM analysis, data analysis, and troubleshooting. An application of QTAP in biological sciences was introduced that utilizes data from inter-strain differences in the protein expression levels of transporters, receptors, tight junction proteins and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice. Among 18 molecules, 13 (abcb1a/mdr1a/P-gp, abcc4/mrp4, abcg2/bcrp, slc2a1/glut1, slc7a5/lat1, slc16a1/mct1, slc22a8/oat3, insr, lrp1, tfr1, claudin-5, Na(+)/K(+)-ATPase, and γ-gtp) were detected in the isolated brain capillaries, and their protein expression levels were within a range of 0.637-101 fmol/μg protein. The largest difference in the levels between the three strains was 2.2-fold for 13 molecules, although bcrp and mct1 displayed statistically significant differences between C57BL/6J and the other strain(s). Highly sensitive simultaneous absolute quantification achieved by QTAP will increase the usefulness of proteomics in biological sciences and is expected to advance the new research field of pharmacoproteomics (PPx).
format Online
Article
Text
id pubmed-3691662
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36916622013-06-28 A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice Uchida, Yasuo Tachikawa, Masanori Obuchi, Wataru Hoshi, Yutaro Tomioka, Yusuke Ohtsuki, Sumio Terasaki, Tetsuya Fluids Barriers CNS Study Protocol Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the identified proteins must also be elucidated, but this is complicated by the inability of conventional proteomic methods to yield quantitative information for protein expression. Thus, a variety of biological systems remain “black boxes”. Quantitative targeted absolute proteomics (QTAP) enables the determination of absolute expression levels (mol) of any target protein, including low-abundance functional proteins, such as transporters and receptors. Therefore, QTAP will be useful for understanding the activities and roles of individual proteins and their differences, including normal/disease, human/animal, or in vitro/in vivo. Here, we describe the study protocols and precautions for QTAP experiments including in silico target peptide selection, determination of peptide concentration by amino acid analysis, setup of selected/multiple reaction monitoring (SRM/MRM) analysis in liquid chromatography–tandem mass spectrometry, preparation of protein samples (brain capillaries and plasma membrane fractions) followed by the preparation of peptide samples, simultaneous absolute quantification of target proteins by SRM/MRM analysis, data analysis, and troubleshooting. An application of QTAP in biological sciences was introduced that utilizes data from inter-strain differences in the protein expression levels of transporters, receptors, tight junction proteins and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice. Among 18 molecules, 13 (abcb1a/mdr1a/P-gp, abcc4/mrp4, abcg2/bcrp, slc2a1/glut1, slc7a5/lat1, slc16a1/mct1, slc22a8/oat3, insr, lrp1, tfr1, claudin-5, Na(+)/K(+)-ATPase, and γ-gtp) were detected in the isolated brain capillaries, and their protein expression levels were within a range of 0.637-101 fmol/μg protein. The largest difference in the levels between the three strains was 2.2-fold for 13 molecules, although bcrp and mct1 displayed statistically significant differences between C57BL/6J and the other strain(s). Highly sensitive simultaneous absolute quantification achieved by QTAP will increase the usefulness of proteomics in biological sciences and is expected to advance the new research field of pharmacoproteomics (PPx). BioMed Central 2013-06-08 /pmc/articles/PMC3691662/ /pubmed/23758935 http://dx.doi.org/10.1186/2045-8118-10-21 Text en Copyright © 2013 Uchida et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Uchida, Yasuo
Tachikawa, Masanori
Obuchi, Wataru
Hoshi, Yutaro
Tomioka, Yusuke
Ohtsuki, Sumio
Terasaki, Tetsuya
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title_full A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title_fullStr A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title_full_unstemmed A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title_short A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
title_sort study protocol for quantitative targeted absolute proteomics (qtap) by lc-ms/ms: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddy, fvb, and c57bl/6j mice
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691662/
https://www.ncbi.nlm.nih.gov/pubmed/23758935
http://dx.doi.org/10.1186/2045-8118-10-21
work_keys_str_mv AT uchidayasuo astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT tachikawamasanori astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT obuchiwataru astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT hoshiyutaro astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT tomiokayusuke astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT ohtsukisumio astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT terasakitetsuya astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT uchidayasuo studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT tachikawamasanori studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT obuchiwataru studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT hoshiyutaro studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT tomiokayusuke studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT ohtsukisumio studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice
AT terasakitetsuya studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice